Prevalence of Vancomycin Intermediate Staphyloccus aureus (VISA) in a tertiary care hospital in Eastern Nepal  by Khanal, B. et al.
e th In
7
C
T
Y
Y
1
2
t
3
h
i
c
p
r
b
s
m
d
(
C
w
1
P
t
I
d
d
d
t
(
(
c
i
b
e
i
w
t
(
3
H
i
ﬁ
c
a
c
H
t
s
d
A
t
7
P
a
B
c
t
o
i
o
S
s
c
t
c
s
t
(
o
A
i
v
d
v
t
t
c
f
s
t
p
o
s
s342 14
3.016
avia porcellus as a model for experimental infection by
rypanosoma cruzi
. Castro Sesquen1,∗, R.H. Gilman2, M. Verastegui1, V.
auri 1, N. Angulo1, D.E. Velasquez Portocarrero1, C. Bern3
Universidad Peruana Cayetano Heredia, Lima, Peru
The Johns Hopkins Bloomberg School of Public Health, Bal-
imore, MD, USA
CDC, Atlanta, AT, USA
Background: Chagas disease remains a major public
ealth concern with 8 to 10 million people already being
nfected, an annual incidence of 200 000 new cases in 15
ountries, and 14.000 deaths associated with the infection
er year. The guinea pig (Cavia porcellus) is one of the major
eservoirs of T. cruzi in Perú and Bolivia, however the num-
er of studies using this mammal is reduced. The aim of this
tudy was to evaluate the use of the guinea pig as an animal
odel for Chagas disease.
Methods: Seventy two guinea pigs were inoculated intra-
ermally with 104 trypomastigotes form of T. cruzi strain Y
Experimental Group, EG) and 12 guinea pigs were used as
ontrol Group (CG). Eight animals from EG and two from CG
ere sacriﬁced at different times (5, 15, 20, 25, 40, 55, 115,
65 and 365 days post infection).
Results: Clinical signs and mortality weren’t observed.
eak of the parasitaemia was at 20 days post infection (pi),
hen decreased and since 55 days pi was negative. Speciﬁc
gM were detected from 15 to 115 days pi. Speciﬁc IgG were
etected at 20 days pi and reached its maximum value at 115
ays pi which were maintained until 365 days pi. k-DNA was
etected in the blood samples from 100% of animals during
he acute phase (5 to 55 days pi), during the chronic phase
115 to 365 days pi) the number of positives dropped to 37%
10/27). Lymphocytic inﬁltrate with some polymorphonu-
lear cells and amastigotes nests were observed by H&E
n the heart, skeletal muscle, intestine, liver, kidney and
rain. k-DNA was detected in the same tissue and in the skin,
sophagus, lung and spleen. The most severe histopatholog-
cal changes and the largest number of amastigotes nests
ere found in the heart. The major degree of inﬂamma-
ion and number of amastigotes were at day 25 pi. Fibrosis
62.5%) and vasculitis (62.5%) were observed in the heart at
65 days pi.
eart tissue from a guinea pig 25 days after T. cruzi
nfection; note the amastigote nests in a cardiac muscle
bers, surrounded by some lymphocytes (H&E, magniﬁ-
ation 500X).
Conclusion: These results indicate that the guinea pig is
good model for infection by T. cruzi as it displays similar
haracteristics to those found in humans.
o
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eart tissue of a guinea pig 365 days after T. cruzi infec-
ion; note foci of ﬁbrosis in the myocardium (Trichromic
taining, magniﬁcation 200X)
oi:10.1016/j.ijid.2010.02.380
ntibiotic Resistance: Gram-Positive (Poster Presen-
ation)
4.001
revalence of Vancomycin Intermediate Staphyloccus
ureus (VISA) in a tertiary care hospital in Eastern Nepal
. Khanal ∗, R. Baral, A. Acharya
BP Koirala Institute of Health Sciences, Dharan, Nepal
Background: Staphylococcus aureus is a leading pathogen
ausing many serious and life threatening infections. Resis-
ant S.aureus has become a serious matter of concern
ver recent years. Knowledge of antimicrobial susceptibil-
ty proﬁle of the local isolates is essential for selection
f appropriate therapy for the effective management of
taphylococcal infections. Present study was undertaken to
tudy the status of antimicrobial resistance among the clini-
al isolates of Staphylococcus aureus with special reference
o the prevalence of Vancomycin Intermediate Staphylococ-
us aureus(VISA).
Methods: S.aureus isolated from the clinical specimens
ubmitted to the microbiology unit of clinical labora-
ory services, BP Koirala Institute of Health Sciences
BPKIHS) hospital were studied. Isolation and identiﬁcation
f S.aureus was done by standard microbiological technique.
ll the isolates were tested for antimicrobial susceptibil-
ty by disc diffusion method. Minimum concentration of
ancomycin required to inhibit the S.aureus isolates was
etermined by using standard agar dilution technique.
Results: A total 300 S.aureus isolates were obtained from
arious clinical specimens .All the isolates were susceptible
o vancomycin in disc diffusion method. However, in MIC
esting 80(26.66%) were found to have intermediate sus-
eptibility to vancomycin (VISA) with MIC (8—16mg/L).MRSA
ormed 26% of total isolates of which 18.42% were VISA. A
igniﬁcant number of VISA isolates were found to be mul-
idrugresistant.Most of the VISA isolates were obtained from
us(71.25%),followed by blood(13%) suggesting association
f VISA more commonly with abscesses and sepsis.
Conclusion: Resistant Staphylococci are prevalent in our
et up. In addition, emergence of S. aureus with reduced
usceptibility to vancomycin has added to the complexity
f problem. Prudent use of antimicrobials and continuous
urveillance are required for early recognition and contain-
ent of spread of this emerging pathogen. Further study on
.aureus infections, its antimicrobial resistance and its cor-
trac
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relation with clinical conditions and epidemiological factors
is recommended in future.
doi:10.1016/j.ijid.2010.02.381
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A worldwide surveillance program studying the In
Vitro Activity of Tigecycline and 10 common therapeu-
tic agents against methicillin-resistant Staphylococcus
aureus and Vancomycinresistant Enterococcus species
from 2004—2009
B. Johnson1,∗, M. Renteria1, J. johnson1, R. Badal1, S.
Bouchillon1, D. Hoban1, M. Dowzicky2
1 International Health Management Associates, Inc.,
Schaumburg, IL, USA
2 Pﬁzer Inc, Collegeville, PA, USA
Background: The T.E.S.T. program determined the in
vitro activity against methicillinresistant S. aureus and
vancomycin-resistant Enterococcus spp. of TIG and 10
antimicrobials commonly prescribed for serious gram-
positive infections: amoxicillin-clavulanic acid (AUG),
piperacillin-tazobactam (PT), levoﬂoxacin (LVX), ceftriax-
one (CAX), linezolid (LZD), minocycline (MIN), vancomycin
(VAN), ampicillin (AMP), penicillin (P), and meropenem
(MER). Study strains were collected from 697 laboratories
in 55 countries globally throughout 2004-2009.
Methods: A total of 27,846 clinical isolates (10,806 ente-
rococci, 17,040 S. aureus) were identiﬁed to the species
level at each participating site and conﬁrmed by a central
laboratory. Minimum Inhibitory Concentrations (MICs) were
determined by the local laboratory using broth microdilution
panels. Antimicrobial resistance was interpreted according
to CLSI breakpoints with TIG susceptible breakpoints deﬁned
as <0.5 mcg/ml for S. aureus and <0.25 mcg/ml for entero-
cocci.
Results: 12.8% (1,381/10,806) of enterococci were resis-
tant to vancomycin (VRE), and 42.1% (7,174/17,040) of S.
aureus were resistant to oxacillin (MRSA). Among the van-
comycin resistant E. faecium (VREF), % resistant rates to
other study drugs were LVX 99.3, P 98.5, AMP 98.3, VAN 100,
MIN 10.8 and LZD 0.2. Percent resistant rates for MRSA were
P 100, AMP 100, AUG 75.4, LVX 74.9, PT 65.8 CAX 46.5, IMP
24.4, MIN 1.3, LZD 0.0, and VAN 0.0. TIG inhibited 100% of
the enterococci and S. aureus resistant to other drugs. Modal
TIG MICs for VRE/nonVRE were 0.12/0.12, and 0.12/0.12 for
MRSA/MSSA.
Conclusion: TIG retained potent activity against drug-
resistant S. aureus and enterococcal isolates, inhibiting
100% of all strains tested at their deﬁned breakpoints of 0.5
and 0.25mcg/ml, respectively.
doi:10.1016/j.ijid.2010.02.382
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he survey of risk factors of multi drug resistant of E.
aecalis isolated from clinical samples
. Moniri
Kashan University of Medical Sciences, Kashan, Iran, Islamic
epublic of
Background: During the last decade, enterococci have
ecome important nosocomial pathogens, representing the
econd leading cause of urinary tract infections. This
ncreasing prevalence has been paralleled by the occurrence
f multi-drug resistant (MDR). The aim of this cross-sectional
revalence study was to determine the prevalence and risk
actors of antibiotic resistance of E. faecalis isolated from
linical samples in hospitalized patients in Kashan, Iran.
Methods: This descriptive study was done on clini-
al specimens isolated from hospitalized patients. From
eptember 2007 to 2008, a total of 106 E.faecalis isolates
ere collected from clinical specimens in Kashan hospi-
als. Antimicrobial susceptibility test was determined with
isk diffusion and minimal inhibitory concentration of van-
omycin assayed by E test.
Results: From 128 isolates were found to consist of Ente-
ococcus faecalis 106(82.8%) and Enterococcus faecium 22
17.2%). Resistance rates for E.faecalis were as follows:
rytromycin 52.8%; ciproﬂoxacin 40.6%; gentamicin, 38.7%;
evoﬂoxacin 34%; penicillin, 29.2%; nitrofurantoin 18.9%;
mpicillin, 11.3%; Imipenem 10.4%; and vancomycin, 4.7%
ll isolate were sensitive to linezolid. Multidrug-resistant
MDR) phenotype (resistance to three or more of drugs)
ccurred in 37.7%. Risk factor for a VRE-positive culture
ere antimicrobial usage within 2 months before culture
P = 0.045).
Conclusion: Emergence of multi-resistant E.faecalis and
igh level resistance to vancomycin shown by E.faecalis
trains is of concern because of the decrease in the ther-
peutic options for treatment of infections caused by
nterococci.
oi:10.1016/j.ijid.2010.02.383
4.004
he relationship between macrolide resistance in Strep-
ococcus pneumoniae and consumption of oral macrolides
n Republic of Croatia and City of Zagreb
. Vranes1,∗, J. Knezevic2, B. Bedenic3, D. Stimac4, N.
arza-Davila4, M. Anusic5
Zagreb Institue of Public Health ‘‘Andrija Stampar’’,
agreb, Croatia
Zagreb Institute of Public Health ‘‘Andrija Stampar’’,
agreb, Croatia
School of Medicine, University of Zagreb, Clinical Hospital
enter Zagreb, Zagreb, Croatia
Zagreb Institute of Public Health ‘‘Andrija Stampar’’,
agreb, Croatia
Zagreb Institute of Public Health, Zagreb, Croatia
Background: The aim of this study was to investigate the
elationship between increased resistance of Streptococcus
neumoniae to macrolides and use of macrolides in Croatia
